Putting some spine into alternative splicing

Trends in Biotechnology

Volumn 21, Issue 8, 2003, Pages 328-330

  Khoo, Bernard ^a   Akker, Scott A ^a   Chew, Shern L ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; DISEASES; GENES;

SPINAL MUSCULAR ATROPHY;

BIOTECHNOLOGY;

ANTISENSE OLIGONUCLEOTIDE; ONCOPROTEIN; PEPTIDE NUCLEIC ACID; PROTEIN; PROTEIN HTRA2 BETA1; PROTEIN SR; SURVIVAL MOTOR NEURON PROTEIN; UNCLASSIFIED DRUG;

BIOTECHNOLOGY;

ALTERNATIVE RNA SPLICING; EXON; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC COMPLEMENTATION; HUMAN; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN NUCLEIC ACID INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SEQUENCE HOMOLOGY; SHORT SURVEY; SPINAL MUSCULAR ATROPHY;

EID: 0142071068     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(03)00168-9     Document Type: Short Survey

References (21)

1. Lefebvre S., et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 80:1995;155-165.
2. Paushkin S., et al. The SMN complex, an assemblyosome of ribonucleoproteins. Curr. Opin. Cell Biol. 14:2002;305-312.
3. Frugier T., et al. The molecular bases of spinal muscular atrophy. Curr. Opin. Genet. Dev. 12:2002;292-298.
4. Lorson C.L., Androphy E.J. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum. Mol. Genet. 9:2000;259-265.
5. Cartegni L., Krainer A. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat. Genet. 30:2002;377-384.
6. Lorson C.L., et al. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl. Acad. Sci. U. S. A. 96:1999;6307-6311.
7. Cartegni L., Krainer A.R. Correction of disease-associated exon skipping by synthetic exon-specific activators. Nat. Struct. Biol. 10:2003;120-125.
8. Skordis L.A., et al. Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 100:2003;4114-4119.
9. Liu H., et al. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat. Genet. 27:2001;55-58.
10. Hofmann Y., et al. Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc. Natl. Acad. Sci. U. S. A. 97:2000;9618-9623.
11. Chang J.G., et al. Treatment of spinal muscular atrophy by sodium butyrate. Proc. Natl. Acad. Sci. U. S. A. 98:2001;9808-9813.
12. Perrine S.P., et al. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N. Engl. J. Med. 328:1993;81-86.
13. Andreassi C., et al. Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum. Mol. Genet. 10:2001;2841-2849.
14. Monneret C. Recent developments in the field of antitumour anthracyclines. Eur. J. Med. Chem. 36:2001;483-493.
15. Shi N., et al. Brain-specific expression of an exogenous gene after i.v. administration. Proc. Natl. Acad. Sci. U. S. A. 98:2001;12754-12759.
16. Pardridge W.M. Drug and gene targeting to the brain with molecular Trojan horses. Nat. Rev. Drug Discov. 1:2002;131-139.
17. Ray A., Norden B. Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future. FASEB J. 14:2000;1041-1060.
18. Tyler B.M., et al. Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression. Proc. Natl. Acad. Sci. U. S. A. 96:1999;7053-7058.
19. Pooga M., et al. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 16:1998;857-861.
20. Shi N., et al. Antisense imaging of gene expression in the brain in vivo. Proc. Natl. Acad. Sci. U. S. A. 97:2000;14709-14714.
21. Cartegni L., et al. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 3:2002;285-298.